- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00172900
MRS and DTI of White Matter in Alzheimer's Disease
December 20, 2005 updated by: National Taiwan University Hospital
MR Spectroscopy and Diffusion Tensor Imaging of White Matter in Alzheimer's Disease
The white matter change of the Alzheimer's disease could be studied by diffusion tensor image and MR spectroscopy to see the microstructral and biochemical change.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ya-Fang Chen, MD
- Phone Number: 5634 886-2-23123456
- Email: avon@ntumc.org
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- Department of Medical Imaging, National Taiwan University Hospital
-
Contact:
- Hon-Man Liu, MD
- Phone Number: 886-2-23562570
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- probable Alzheimer's disease or subcortica type vascular dementia
Exclusion Criteria:
- large vessel infarct, major trauma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Ya-Fang Chen, MD, Department of Medical Imaging, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 15, 2005
Study Record Updates
Last Update Posted (Estimate)
December 21, 2005
Last Update Submitted That Met QC Criteria
December 20, 2005
Last Verified
June 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Neurocognitive Disorders
- Neurodegenerative Diseases
- Tauopathies
- Intracranial Arterial Diseases
- Intracranial Arteriosclerosis
- Leukoencephalopathies
- Dementia
- Alzheimer Disease
- Dementia, Vascular
Other Study ID Numbers
- 9461700320
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Dementia
-
Samsung Medical CenterDong-A Pharmaceutical Co., Ltd.UnknownVascular Dementia | Subcortical Vascular DementiaKorea, Republic of
-
University Health Network, TorontoCompleted
-
Maastricht University Medical CenterCompletedVascular Dementia | Post-stroke Depression | Vascular Cognitive Impairment | Post-stroke Apathy | Post-stroke DementiaNetherlands
-
Charsire Biotechnology Corp.CompletedAlzheimer's Disease or Vascular DementiaUnited States
-
Tianjin Medical University General HospitalUnknownCerebral Small Vessel Diseases | Subcortical Vascular DementiaChina
-
Yamei TangRecruitingCognitive Impairment | Alzheimer Disease | MCI | VAD - Vascular DementiaChina
-
Merz Pharmaceuticals GmbHLLC Merz Pharma, RussiaCompleted
-
Dongzhimen Hospital, BeijingCompletedVascular DementiaChina
-
Peking University First HospitalZhejiang Otsuka Pharmaceutical Co., Ltd.CompletedStroke | Vascular DementiaChina
-
Eisai Inc.Eisai Co., Ltd.CompletedVascular DementiaPhilippines